You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

10-051

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Seoul (CKR-051 Dose 1, CKR-051 Dose 2, CKR-051 Dose 3)

Not yet recruiting
  • Healthy
  • CKR-051 Dose 1
  • +4 more
  • (no location specified)
Apr 18, 2023

COVID-19 Pandemic Trial (INNA-051, Placebo)

Withdrawn
  • COVID-19 Pandemic
  • (no location specified)
Apr 7, 2022

Melanoma, Lymphoma, Solid Tumor Trial in Worldwide (Pembrolizumab)

Recruiting
  • Melanoma
  • +4 more
  • Pembrolizumab
  • Aurora, Colorado
  • +18 more
Jan 5, 2023

Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis Trial in Worldwide (AMB-05X)

Active, not recruiting
  • Tenosynovial Giant Cell Tumor
  • Pigmented Villonodular Synovitis
  • AMB-05X
  • Columbus, Ohio
  • +5 more
Oct 5, 2022

NSCLC (NSCLC), Renal Cell Carcinoma (RCC), Malignant Melanoma (MEL) Trial in Russian Federation (GNR-051)

Recruiting
  • Non-Small Cell Lung Cancer (NSCLC), Renal Cell Carcinoma (RCC), Malignant Melanoma (MEL)
  • GNR-051
  • Kazan, Russian Federation
  • +11 more
Sep 21, 2021

Osteoporosis, Postmenopausal Trial (MK0217, alendronate sodium / Duration of Treatment : 5 Years, Comparator : (unspecified)

Completed
  • Osteoporosis, Postmenopausal
  • MK0217, alendronate sodium / Duration of Treatment : 5 Years
  • Comparator : placebo (unspecified) /Duration of Treatment : 5 Years
  • (no location specified)
Feb 1, 2022

Plaque Psoriasis, Skin Diseases Trial in Canada, United States (JTE-051, Placebo)

Terminated
Has Results
  • Plaque Psoriasis
  • Skin Diseases
  • Fountain Valley, California
  • +15 more
Jul 15, 2021

Pigmented Villonodular Synovitis, TGCT, Tenosynovial Giant Cell Tumor Trial (AMB-05X)

Not yet recruiting
  • Pigmented Villonodular Synovitis
  • +2 more
  • AMB-05X
  • (no location specified)
Apr 22, 2022

Rheumatoid Arthritis Trial in Worldwide (JTE-051, Placebo)

Completed
Has Results
  • Rheumatoid Arthritis
  • Tucson, Arizona
  • +38 more
Jun 11, 2021

Influenza Prophylaxis Trial in London (INNA-051, Placebo)

Recruiting
  • Influenza Prophylaxis
  • London, United Kingdom
    hVIVO
Apr 7, 2022

Healthy Volunteers Trial in West Bend (BT051 100mg, BT051 300mg, BT051 700mg)

Completed
  • Healthy Volunteers
  • BT051 100mg
  • +5 more
  • West Bend, Wisconsin
    Spaulding Clinical Research, LLC
Mar 24, 2022

Non-Cystic Fibrosis Bronchiectasis Trial in Worldwide (Brensocatib 10 mg, Brensocatib 25 mg, Placebo)

Recruiting
  • Non-Cystic Fibrosis Bronchiectasis
  • Brensocatib 10 mg
  • +2 more
  • Birmingham, Alabama
  • +416 more
Jan 24, 2023

Missing Teeth Trial in Groningen (One or two dental implants (Biomet3I dental implant system) were placed 10 years ago)

Recruiting
  • Missing Teeth
  • One or two dental implants (Biomet3I dental implant system) were placed 10 years ago
  • Groningen, Netherlands
    Dept Oral and Maxillofacial Surgery UMCG
Dec 6, 2022

Osteoarthritis, Knee Trial in Bologna (Personalised Musculoskeletal Modeling)

Recruiting
  • Osteoarthritis, Knee
  • Personalised Musculoskeletal Modeling
  • Bologna, Italy
    IRCCS Istituto Ortopedico Rizzoli
Apr 5, 2023

Clinical and Radiographic Outcomes of Dental Implant Therapy

Completed
  • Peri-Implantitis
    • Gothenburg, Sweden
      Department of Periodontology, Institute of Odontology
    Mar 16, 2022

    Dental Implant, Tooth Extraction, Bone Resorption Trial in Alicante (Dental implant placement after tooth extraction)

    Recruiting
    • Dental Implant
    • +2 more
    • Dental implant placement after tooth extraction
    • Alicante, Spain
      Clínica Dental Esteve
    Jan 10, 2023

    Prostatic Tumors, Prostatic Cancer Trial run by the NCI (ETBX-071; adenoviral PSA vaccine, ETBX-061; adenoviral MUC1 vaccine,

    Completed
    Has Results
    • Prostatic Neoplasms
    • Prostatic Cancer
    • ETBX-071; adenoviral PSA vaccine
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Apr 28, 2021

    Salivary Oxidant and Antioxidant Levels in Peri-implant Health

    Completed
    • Peri-Implantitis
    • +4 more
      • (no location specified)
      Feb 2, 2023

      Molar, Third, Periodontal Pocket Trial in Alcorcón ("Distal Flap Reduction" Group, "Only Exodontia" Group)

      Recruiting
      • Molar, Third
      • Periodontal Pocket
      • "Distal Flap Reduction" Group
      • "Only Exodontia" Group
      • Alcorcón, Madrid, Spain
        Clinica Universitaria Universidad Rey Juan Carlos
      Feb 9, 2023

      COVID-19 Trial in Honolulu (Telmisartan 40mg, Placebo)

      Terminated
      • COVID-19
      • Telmisartan 40mg
      • Placebo
      • Honolulu, Hawaii
        University of Hawaii - Manoa, John A Burns School of Medicine UH
      Jun 27, 2022

      Calcular Obstructive Jaundice Trial in Sohag (sphincterotomy, precutting of the papilla by knife needle)

      Recruiting
      • Calcular Obstructive Jaundice
      • sphincterotomy
      • precutting of the papilla by knife needle
      • Sohag, Egypt
        Sohag university Hospital
      Oct 27, 2023

      Recession, Gingival, Surgical Procedure, Unspecified, Graft Complication Trial in Ann Arbor (Surgical Blade, Mucotome, Diamond

      Not yet recruiting
      • Recession, Gingival
      • +3 more
      • Surgical Blade
      • +3 more
      • Ann Arbor, Michigan
        University of Michigan School of Dentistry
      Jul 12, 2023

      Chronic Periodontitis Trial in Nagpur (PRP combined with DFDBA, DFDBA)

      Completed
      • Chronic Periodontitis
      • PRP combined with DFDBA
      • DFDBA
      • Nagpur, Maharashtra, India
        212, Department of Periodontology, Government Dental college and
      May 23, 2023

      Increased Number of Previous Early Miscarriages?

      Not yet recruiting
      • Infertility, Female
      • +3 more
      • Transvaginal ultrasound
      • Blood test AMH
      • Abu Dhabi, United Arab Emirates
      • +2 more
      Jul 24, 2023

      Pulmonary Disease, Chronic Obstructive Trial (ECCO2R, NIV)

      Not yet recruiting
      • Pulmonary Disease, Chronic Obstructive
      • ECCO2R
      • NIV
      • (no location specified)
      Dec 29, 2022